RapidClaims offers an autonomous coding solution, RapidCode, as part of an AI-powered revenue cycle management platform. RapidCode is live in more than 20 specialties and processes millions of charts. The product delivers 100% chart coverage and reaches 98% accuracy in specialties such as radiology, anesthesia, and labs. It maintains 94%+ accuracy in more complex fields like surgeries. Led by CEO and founder Dushyant Mishra, the company intends to use new funding to accelerate go-to-market efforts and enhance its technology. RapidClaims builds AI-driven products to tackle medical claim denials and streamline the medical coding process. Its flagship RapidCode is a fully autonomous medical coding solution designed to eliminate manual errors and improve efficiency. RapidAssist helps human coders by identifying documentation gaps and suggesting appropriate codes, while RapidRisk provides risk-adjusted coding scores to improve reimbursement accuracy. The company launched a beta product and secured six pilot programs within two months, with five more pilots in the pipeline. RapidClaims cites a large market opportunity, noting US healthcare organizations face $256 billion in annual losses from denied claims. The startup recently raised $3.1M in seed funding to advance its products and growth.

Total raised

$14M

Funding rounds

3

Latest round

Seed

Latest activity

Apr 2025